Langerhans Cell Histiocytosis (LCH) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)
Condition: Histiocytosis, Langerhans-Cell Interventions: Other: Biospecimen Collection; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration Sponsors: Children's Oncology Group; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2019 Category: Research Source Type: clinical trials
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Conditions: Langerhan's Cell Histiocytosis; Juvenile Xanthogranuloma; Erdheim-Chester Disease; Rosai Dorfman Disease; Neuro-Degenerative Disease; Histiocytic Sarcoma; Histiocytic Disorders, Malignant Intervention: Drug: Cobimetinib Sponsors: Carl Allen; Texas Children's Hospital; North American Consortium for Histiocytosis; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2019 Category: Research Source Type: clinical trials
